
May 25, 2026
Roche Enters Into a Definitive Merger Agreement to Acquire PathAI to Transform AI-Driven Diagnostics
Roche has entered a definitive merger agreement to acquire PathAI, aiming to enhance AI-driven diagnostics in pathology.The acquisition of PathAI, a leader in digital pathology and AI technology, is set to bolster Roche's existing capabilities in companion diagnostics. This move follows a successful partnership initiated in 2021, which has now evolved to include the development of AI-enabled diagnostic algorithms. The deal is expected to close in the latter half of the year, after which PathAI w









